Calpeptin Promotes Osteogenesis through the Dlx3-RUNX2 Pathway: In Vitro and In Vivo Evidence for a Dual-Action Osteoporosis Therapy
{{output}}
Osteoporosis is a common systemic skeletal disease characterized by altered bone metabolism, decreased bone mass, deteriorated microstructure, and an increased risk of fractures. Current treatments primarily focus on inhibiting bone resorption to reduce bone l... ...
